All news releases and other materials below speak as of the date of their issuance, and are provided for historical reference purposes only. They contain information that was current at the time of the issuance, but that may no longer be current. Readers should not rely on the continued accuracy of any such material. All readers should carefully check the dates of issuance of these materials. Milacron assumes no obligation and does not intend to update, correct or modify any of the material contained in the documents below.

To see 2008 News releases, click one of the links below.

December 11, 2008
Ross Anderson to Head N.A. Machinery; John Francy New CFO; Bob McKee to Lead DME
Milacron today announced Ross Anderson as president – machinery technologies North America, the company’s largest operating segment, replacing Dave Bertke, who is retiring at year-end. Current treasurer John Francy is now vice president – finance and CFO, filling Anderson’s previous position. Bob McKee, currently president of global industrial fluids, will also head up the company’s global mold technologies segment, previously led by Dave Lawrence, who became Milacron’s president and CEO last week. In addition, controller Danny Gamez was named a vice president with additional responsibilities.
Full Story

November 18, 2008
Dave Lawrence Named Milacron CEO
Milacron announced that its board of directors has elected David E. Lawrence president and chief executive officer of the company and a member of the board of directors, effective December 1, 2008. A 35-year veteran of the plastics industry, Lawrence, 58, has been president of global mold technologies for Milacron for the past five years.  He replaces Ronald D. Brown, Milacron’s chief executive officer since 2001 and a board member since 1999. Brown announced in April his intention to retire by the end of the year.
Full Story

November 5, 2008
Milacron's Operating Earnings Improve; Focus on Cost Reductions Continues
Milacron reported a net loss for the quarter ended September 30 of $2.6 million, or 93 cents per share, compared to a net loss in the third quarter of 2007 of $4.5 million, or $1.36 per share. The profit improvement was a result of aggressive overhead cost reductions, which boosted operating earnings to $6.5 million in the quarter versus $3.0 million in the third quarter a year ago. Year to date, operating earnings have improved to $14.5 million compared to $3.6 million in 2007.
Full Story | Financial Statements

October 7, 2008
Milacron Sets Q3 Earnings Release and Investor Call for November 5
Milacron will release its third-quarter 2008 results on Wednesday, November 5, in the morning prior to the stock market opening.  Also that day at 1 p.m. EDT, Milacron will conduct an investor conference call, which will be webcast live on the company’s website, www.milacron.com.
Full Story

August 20, 2008
Milacron Reduces Board Size
Milacron has decreased the size of its board of directors from eleven seats to seven in order to improve efficiency and effectiveness.
Full Story

July 31, 2008
Milacron's Sales, Margins and Operating Earnings Continue to Improve
Milacron reported a net loss for the second quarter of $3.1 million, or $1.04 per share. Manufacturing margins in the quarter rose sharply to 22.3% from 19.6% a year ago, and operating earnings more than doubled to $6.5 million from $2.6 million.
Full Story | Financial Statements

July 7, 2008
Milacron Sets Earnings Release and Investor Call for July 31
Milacron will release its second-quarter 2008 results on Thursday, July 31, in the morning prior to the stock market opening.  Also that day at 1 p.m. EDT, Milacron will conduct an investor conference call, which will be webcast live on the company’s website, www.milacron.com. 
Full Story

May 20, 2008
Milacron Common Stock to Move to OTC Trading
Milacron announced that its common stock will be quoted on over-the-counter markets beginning Tuesday, May 27. The company expects its stock to continue to be actively traded in one of the premium tiers of the Pink Sheets and is taking appropriate steps to be quoted on the OTC Bulletin Board as well.
Full Story

May 6, 2008
Milacron’s First Quarter Results Improve Year Over Year
Milacron reported a net loss of $6.9 million, or $1.76 per diluted share, in the first quarter ended March 31. Sales were up 7% and manufacturing margins improved to 19.0%...
Full Story | Financial Statements

April 24, 2008
Milacron's D-M-E Forms Global Strategic Alliance with Japan's Futaba
Milacron announced that its mold technologies unit, D-M-E Company, has entered into a strategic alliance with Futaba Corporation in Japan.
Full Story

April 18, 2008
Milacron CEO Ron Brown to Retire
Milacron announced today that chairman, president and chief executive officer Ronald D. Brown intends to retire by the end of the year.
Full Story

April 16, 2008
Milacron Sets Q1 Earnings Release and Investor Call for May 6
Milacron will release its first-quarter 2008 results on Tuesday, May 6, in the morning prior to the stock market opening.
Full Story | Investor Conference Call

March 13, 2008
Milacron Signs 5-Year, €27 Million Credit Deal
Milacron announced the signing of a five-year, asset-based revolving credit program through which Lloyds TSB Group plc will provide as much as €27 million of aggregate financing…
Full Story

February 25, 2008
Milacron Reports Q4 and Year-End 2007 Results; Sales Up 10% in Fourth Quarter
Milacron reported a net loss in the fourth quarter of 2007 of $73.4 million, or $14.66 per diluted share, caused primarily by a non-cash writedown of deferred tax assets of $63.0 million…
Full Story | Preliminary Financial Statements | Final, Audited Financial Statements

January 23, 2008
Milacron Sets Q4 Earnings Release and Investor Call for February 25
Milacron will release its 2007 fourth-quarter and year-end results on Monday, February 25, in the morning prior to the stock market opening and will also conduct an investor conference call…
Full Story

Releases are entered "as issued" historically and are believed to be accurate at the time. No attempt is made to correct or update them based on subsequent events. Shareholders and potential investors should note the date of issue on the document when evaluating forward-looking statements and consult the Cautionary Statement, which spells out risks and uncertainties that could impact future results, in the company's most recent Form 10-Q or Form 10-K on file with the SEC.